A state and a biopharmaceutical company agreed recently on a new way to pay for treating patients with Hepatitis C, the most deadly infectious disease in America. The agreement, however, fell short of the solution that Louisiana worked hard to put into place.
Louisiana Tries Hard, But Federal Obstacles Cause Hepatitis C Plan To Fall Short
